Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$6.37 - $15.23 $276,598 - $661,317
-43,422 Reduced 76.9%
13,041 $197,000
Q2 2022

Aug 16, 2022

BUY
$4.95 - $9.16 $279,491 - $517,201
56,463 New
56,463 $423,000
Q1 2022

May 17, 2022

SELL
$5.64 - $9.8 $350,007 - $608,168
-62,058 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$7.02 - $13.33 $363,664 - $690,547
51,804 Added 505.21%
62,058 $436,000
Q3 2021

Nov 16, 2021

BUY
$11.32 - $16.63 $116,075 - $170,524
10,254 New
10,254 $117,000
Q2 2021

Aug 16, 2021

SELL
$15.16 - $18.97 $210,617 - $263,550
-13,893 Closed
0 $0
Q1 2021

May 18, 2021

SELL
$13.12 - $20.9 $356,365 - $567,685
-27,162 Reduced 66.16%
13,893 $249,000
Q4 2020

Feb 17, 2021

BUY
$9.12 - $14.49 $108,892 - $173,010
11,940 Added 41.01%
41,055 $555,000
Q2 2020

Aug 17, 2020

BUY
$12.0 - $16.13 $349,380 - $469,624
29,115 New
29,115 $430,000
Q1 2020

May 15, 2020

SELL
$11.84 - $25.52 $365,808 - $788,465
-30,896 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$17.72 - $25.1 $547,477 - $775,489
30,896 New
30,896 $747,000
Q4 2018

Feb 15, 2019

SELL
$33.0 - $60.04 $146,289 - $266,157
-4,433 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$56.15 - $73.9 $248,912 - $327,598
4,433 New
4,433 $273,000
Q1 2018

May 15, 2018

SELL
$51.15 - $61.0 $509,760 - $607,926
-9,966 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$50.85 - $65.1 $266,301 - $340,928
5,237 Added 110.74%
9,966 $595,000
Q3 2017

Nov 14, 2017

BUY
$48.6 - $60.1 $229,829 - $284,212
4,729
4,729 $230,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.